Bactiguard Holding

Business and Financial Review • Mar 12, 2015

Press release Stockholm, 12 March 2015

Bactiguard expands in Europe

Bactiguard expands in Europe by entering an exclusive distribution agreement for Switzerland, covering all products in the Bactiguard Infection Protection portfolio.

"We are delighted about our expansion in Switzerland, a market recognized for its high quality healthcare. We have managed to break into one of Europe's toughest markets, which strengthens the brand and our market position in Europe", says Johan Rugfelt, CEO.

In Switzerland, with a population of 8 million people, nearly 11 percent of GDP is spent on healthcare. The overall prevalence of healthcare associated infections (HAI) is approximately 11 percent. HAI and multi-resistant bacteria is a major challenge, like in the rest of the world. Implementing preventive measures, such as Bactiguard's catheters for the urinary- and respiratory tract and the bloodstream is therefore essential to tackle this severe problem.

The Swiss distributor, GD Medical is a family owned company, based in Freienbach. The company has been marketing and distributing equipment for surgery, intensive care and diagnostics and other medical devices since 2006.

"Switzerland provides high quality healthcare and is at the forefront of implementing innovations. The need for preventive solutions to combat healthcare associated infections is high and we are looking forward to selling Bactiguard's high-technology products, increasing patient safety and saving cost for the healthcare system", says Gabriel Dürst, CEO GD Medical.

For further information, please contact:

Cecilia Edström, Director of Sales, Marketing & Communications, mobile: +46 722 262 328

About Bactiguard

Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company's patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth

on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, South America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com.